The HDACi vorinostat reduces MDSC accumulation in the spleen, blood, and tumor bed but increases the proportion of IFN-γ- or CD8+ T cells in BALB/C mice bearing 4T1 tumors (148). This evidence concerns the gene CD8A and neoplasm.